Search

Treatment for cause of sudden sight loss now available through the NHS in England

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

NICE approves treatment for cause of sudden sight loss

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

2018/19 Ophthalmology Honours results announced

Recipients of the 2018/19 Ophthalmology Honours by Bayer were recognised during a presentation held at BMA House, London.

Gene Vision launched to support those diagnosed with genetic eye diseases

A new website, Gene Vision (https://gene.vision), has been developed by Professor Mariya Moosajee and Dr Alex Yeong, supported by Dr Peter Thomas (Director of Digital Innovation at Moorfields Eye Hospital). The new site is intended for adults, children and their families who are diagnosed with rare genetic eye diseases.

Novel retinal pigment metric tackles bias in AI models

Researchers have developed an innovative metric for objectively classifying pigmentation in a retinal image, rather than using subjective social constructs like ethnicity or other demographic variables, as is currently the case when building health datasets. Called the Retinal Pigment Score...

Clinical trial investigates ‘Light Touch’ approach to wet AMD treatment

A clinical trial led by NIHR Moorfields Clinical Research Facility will explore a new ‘light-touch’ treatment approach for patients with neovascular age-related macular degeneration (wet AMD) that could result in fewer injections and reduced number of clinic visits. Funded by...

Parents urged to get children checked for dry eye disease

Dry eye disease (DED) has become a feature of teenage and young adult life, rather than a condition which traditionally troubled only the middle-aged. The problem is largely unrecognised, says a leading figure in children’s vision and eyecare, Prof James...

In a new international eye study, nearly one in five patients report encountering bogus treatments

An international study, supported by NIHR Biomedical Research Centre: Moorfields, of almost 1,000 people living with sight loss, found that nearly one in five reported receiving or encountering eye treatments they believed to be ‘bogus’. The study raises concerns in...